Laporan Laba Rugi (TTM)
Laporan Laba Rugi AstraZeneca PLC - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25,871 | 26,617 | 27,583 | 29,528 | 32,816 | 37,417 | 41,487 | 44,038 | 45,155 | 44,351 | 43,840 | 44,485 | 44,994 | 45,811 | 47,611 | 49,133 | 51,206 | 54,073 | 54,982 | 56,501 |
| Change (%) | 2.88 | 3.63 | 7.05 | 11.14 | 14.02 | 10.88 | 6.15 | 2.54 | -1.78 | -1.15 | 1.47 | 1.14 | 1.82 | 3.93 | 3.20 | 4.22 | 5.60 | 1.68 | 2.76 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 5,079 | 5,246 | 5,690 | 6,897 | 9,284 | 12,005 | 11,446 | 12,253 | 11,478 | 8,641 | 7,013 | 5,975 | 5,088 | 8,040 | 8,353 | 8,576 | 8,943 | 9,638 | 9,653 | 10,021 |
| Change (%) | 3.29 | 8.46 | 21.21 | 34.61 | 29.31 | -4.66 | 7.05 | -6.32 | -24.72 | -18.84 | -14.80 | -14.85 | 58.02 | 3.89 | 2.67 | 4.28 | 7.77 | 0.16 | 3.81 | |
| % of Revenue | 19.63 | 19.71 | 20.63 | 23.36 | 28.29 | 32.08 | 27.59 | 27.82 | 25.42 | 19.48 | 16.00 | 13.43 | 11.31 | 17.55 | 17.54 | 17.45 | 17.46 | 17.82 | 17.56 | 17.74 |
| Gross Operating Profit | 20,792 | 21,371 | 21,893 | 22,631 | 23,532 | 25,412 | 30,041 | 31,785 | 33,677 | 35,710 | 36,827 | 38,510 | 39,906 | 37,771 | 39,258 | 40,557 | 42,263 | 44,435 | 45,329 | 46,480 |
| Change (%) | 2.78 | 2.44 | 3.37 | 3.98 | 7.99 | 18.22 | 5.81 | 5.95 | 6.04 | 3.13 | 4.57 | 3.63 | -5.35 | 3.94 | 3.31 | 4.21 | 5.14 | 2.01 | 2.54 | |
| % of Revenue | 80.37 | 80.29 | 79.37 | 76.64 | 71.71 | 67.92 | 72.41 | 72.18 | 74.58 | 80.52 | 84.00 | 86.57 | 88.69 | 82.45 | 82.46 | 82.55 | 82.54 | 82.18 | 82.44 | 82.26 |
| SG&A | 10,909 | 11,586 | 11,808 | 12,270 | 13,651 | 14,673 | 15,623 | 17,232 | 17,425 | 17,460 | 17,425 | 17,732 | 18,258 | 18,025 | 18,462 | 18,406 | 18,219 | 19,453 | 19,397 | 19,320 |
| Change (%) | 6.21 | 1.92 | 3.91 | 11.26 | 7.49 | 6.47 | 10.30 | 1.12 | 0.20 | -0.20 | 1.76 | 2.97 | -1.28 | 2.42 | -0.30 | -1.02 | 6.77 | -0.29 | -0.40 | |
| % of Revenue | 42.17 | 43.53 | 42.81 | 41.55 | 41.60 | 39.21 | 37.66 | 39.13 | 38.59 | 39.37 | 39.75 | 39.86 | 40.58 | 39.35 | 38.78 | 37.46 | 35.58 | 35.98 | 35.28 | 34.19 |
| R&D | 5,653 | 5,901 | 6,448 | 6,888 | 7,831 | 8,049 | 8,535 | 9,184 | 9,134 | 9,669 | 9,642 | 9,782 | 9,922 | 10,373 | 10,816 | 11,206 | 11,749 | 12,243 | 12,559 | 13,058 |
| Change (%) | 4.39 | 9.27 | 6.82 | 13.69 | 2.78 | 6.04 | 7.60 | -0.54 | 5.86 | -0.28 | 1.45 | 1.43 | 4.55 | 4.27 | 3.61 | 4.85 | 4.20 | 2.58 | 3.97 | |
| % of Revenue | 21.85 | 22.17 | 23.38 | 23.33 | 23.86 | 21.51 | 20.57 | 20.85 | 20.23 | 21.80 | 21.99 | 21.99 | 22.05 | 22.64 | 22.72 | 22.81 | 22.94 | 22.64 | 22.84 | 23.11 |
| OpEx | 20,768 | 22,247 | 23,562 | 25,689 | 30,625 | 34,520 | 35,713 | 38,854 | 38,162 | 35,539 | 33,811 | 33,212 | 32,992 | 36,163 | 37,389 | 37,921 | 38,689 | 41,144 | 41,372 | 42,150 |
| Change (%) | 7.12 | 5.91 | 9.03 | 19.21 | 12.72 | 3.46 | 8.80 | -1.78 | -6.87 | -4.86 | -1.77 | -0.66 | 9.61 | 3.39 | 1.42 | 2.03 | 6.35 | 0.55 | 1.88 | |
| % of Revenue | 80.28 | 83.58 | 85.42 | 87.00 | 93.32 | 92.26 | 86.08 | 88.23 | 84.51 | 80.13 | 77.12 | 74.66 | 73.33 | 78.94 | 78.53 | 77.18 | 75.56 | 76.09 | 75.25 | 74.60 |
| Operating Income | 5,103 | 4,370 | 4,021 | 3,839 | 2,191 | 2,897 | 5,774 | 5,184 | 6,993 | 8,812 | 10,029 | 11,273 | 12,002 | 9,648 | 10,222 | 11,212 | 12,517 | 12,929 | 13,610 | 14,351 |
| Change (%) | -14.36 | -7.99 | -4.53 | -42.93 | 32.22 | 99.31 | -10.22 | 34.90 | 26.01 | 13.81 | 12.40 | 6.47 | -19.61 | 5.95 | 9.68 | 11.64 | 3.29 | 5.27 | 5.44 | |
| % of Revenue | 19.72 | 16.42 | 14.58 | 13.00 | 6.68 | 7.74 | 13.92 | 11.77 | 15.49 | 19.87 | 22.88 | 25.34 | 26.67 | 21.06 | 21.47 | 22.82 | 24.44 | 23.91 | 24.75 | 25.40 |
| Interest Expense | -684 | -738 | -709 | -706 | -717 | -776 | -809 | -794 | -798 | -917 | -946 | -1,065 | -1,112 | -1,219 | -1,267 | -1,280 | -1,351 | -1,403 | -1,339 | -1,332 |
| Change (%) | 7.89 | -3.93 | -0.42 | 1.56 | 8.23 | 4.25 | -1.85 | 0.50 | 14.91 | 3.16 | 12.58 | 4.41 | 9.62 | 3.94 | 1.03 | 5.55 | 3.85 | -4.56 | -0.52 | |
| % of Revenue | -2.64 | -2.77 | -2.57 | -2.39 | -2.18 | -2.07 | -1.95 | -1.80 | -1.77 | -2.07 | -2.16 | -2.39 | -2.47 | -2.66 | -2.66 | -2.61 | -2.64 | -2.59 | -2.44 | -2.36 |
| Net Income | 2,497 | 3,196 | 3,977 | 3,771 | 1,471 | 112 | -1,063 | -1,253 | 2,040 | 3,288 | 4,705 | 6,163 | 5,896 | 5,955 | 6,331 | 6,440 | 6,495 | 7,035 | 7,772 | 8,295 |
| Change (%) | 27.99 | 24.44 | -5.18 | -60.99 | -92.39 | -1,049.11 | 17.87 | -262.81 | 61.18 | 43.10 | 30.99 | -4.33 | 1.00 | 6.31 | 1.72 | 0.85 | 8.31 | 10.48 | 6.73 | |
| % of Revenue | 9.65 | 12.01 | 14.42 | 12.77 | 4.48 | 0.30 | -2.56 | -2.85 | 4.52 | 7.41 | 10.73 | 13.85 | 13.10 | 13.00 | 13.30 | 13.11 | 12.68 | 13.01 | 14.14 | 14.68 |
Source: Capital IQ
